Bank of New York Mellon’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-249,362
| Closed | -$10.2M | – | 4184 |
|
|
2024
Q2 | $10.2M | Sell |
249,362
-40,282
| -14% | -$1.65M | ﹤0.01% | 1949 |
|
|
2024
Q1 | $12.2M | Sell |
289,644
-21,274
| -7% | -$899K | ﹤0.01% | 1858 |
|
|
2023
Q4 | $13.2M | Buy |
310,918
+47,228
| +18% | +$2M | ﹤0.01% | 1827 |
|
|
2023
Q3 | $5.76M | Buy |
263,690
+3,590
| +1% | +$78.4K | ﹤0.01% | 2238 |
|
|
2023
Q2 | $8.27M | Buy |
260,100
+24,402
| +10% | +$776K | ﹤0.01% | 2039 |
|
|
2023
Q1 | $5.75M | Buy |
235,698
+886
| +0.4% | +$21.6K | ﹤0.01% | 2225 |
|
|
2022
Q4 | $7.41M | Buy |
234,812
+8,407
| +4% | +$265K | ﹤0.01% | 2110 |
|
|
2022
Q3 | $6.4M | Buy |
226,405
+17,863
| +9% | +$505K | ﹤0.01% | 2158 |
|
|
2022
Q2 | $5.51M | Sell |
208,542
-198,621
| -49% | -$5.25M | ﹤0.01% | 2250 |
|
|
2022
Q1 | $14.3M | Sell |
407,163
-33,170
| -8% | -$1.16M | ﹤0.01% | 1877 |
|
|
2021
Q4 | $14.3M | Buy |
440,333
+17,172
| +4% | +$557K | ﹤0.01% | 1913 |
|
|
2021
Q3 | $12.5M | Buy |
423,161
+40,670
| +11% | +$1.2M | ﹤0.01% | 2000 |
|
|
2021
Q2 | $9.8M | Sell |
382,491
-448,297
| -54% | -$11.5M | ﹤0.01% | 2146 |
|
|
2021
Q1 | $11.4M | Buy |
830,788
+809,151
| +3,740% | +$11.1M | ﹤0.01% | 2017 |
|
|
2020
Q4 | $359K | Buy |
+21,637
| New | +$359K | ﹤0.01% | 3758 |
|